NPR5 Antibody

What is NPR-C and what biological functions does it serve?

NPR-C (also known as NPR3, ANPRC, or Atrial natriuretic peptide receptor type C) functions as a receptor for natriuretic peptide hormones, binding with similar affinities to atrial natriuretic peptide (NPPA/ANP), brain natriuretic peptide (NPPB/BNP), and C-type natriuretic peptide (NPPC/CNP) . Unlike other natriuretic peptide receptors, NPR-C does not possess guanylate cyclase activity, which is crucial for understanding its functional mechanisms .

NPR-C primarily serves as a clearance receptor for natriuretic peptides, regulating their local concentrations and physiological effects . This clearance function plays a vital role in preventing excessive signaling that could otherwise lead to pathological conditions . Additionally, NPR-C may regulate several critical physiological processes including diuresis, blood pressure control, and skeletal development . The receptor's regulatory role in these processes makes it a significant target for research in cardiovascular, renal, and skeletal biology.

What types of NPR-C antibodies are available for research purposes?

Researchers have access to multiple types of NPR-C antibodies with different characteristics suitable for various experimental applications:

The rabbit polyclonal antibody from Abcam (ab14355) is generated against a synthetic peptide within human NPR3 (amino acids 150-250) conjugated to Keyhole Limpet Haemocyanin . This antibody has been cited in 6 publications, suggesting reliability in research settings .

The mouse monoclonal antibody from Santa Cruz Biotechnology (E-5) is available in both non-conjugated form and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor conjugates . These options provide flexibility for different experimental designs and detection methods.

How can researchers validate NPR-C antibody specificity in their experimental systems?

Validating antibody specificity is crucial for obtaining reliable research results. For NPR-C antibodies, researchers should implement a multi-step validation process:

First, perform western blotting to confirm that the antibody detects a protein of the expected molecular weight for NPR-C. Compare results with positive and negative control samples, including NPR-C knockout or knockdown cells if available.

Second, verify specificity through immunocytochemistry/immunofluorescence (ICC/IF) assays by examining the subcellular localization pattern. NPR-C is primarily membrane-localized, so staining should reflect this pattern. The Abcam antibody (ab14355) has been validated for ICC/IF applications with human samples, as demonstrated in their stained HeLa cells images .

Third, consider using complementary techniques such as immunoprecipitation followed by mass spectrometry to confirm that the antibody is pulling down NPR-C specifically. The Santa Cruz antibody (E-5) is validated for immunoprecipitation, making it suitable for this application .

Finally, include appropriate controls in each experiment, such as secondary antibody-only controls and isotype controls for monoclonal antibodies, to rule out non-specific binding.

How can NPR-C antibodies be applied to study cardiovascular and renal pathologies?

NPR-C antibodies serve as powerful tools for investigating the pathophysiology of cardiovascular and renal disorders where natriuretic peptide system dysregulation is commonly observed . Several methodological approaches can be implemented:

In hypertension studies, researchers can use NPR-C antibodies in immunohistochemistry to examine receptor expression patterns in vascular tissues from hypertensive versus normotensive subjects. This may reveal altered expression or localization of NPR-C, providing insights into the mechanistic involvement of the clearance receptor in blood pressure regulation .

For congestive heart failure investigations, western blotting with NPR-C antibodies allows quantification of receptor levels in cardiac tissue samples. Correlating these levels with disease severity and natriuretic peptide concentrations can illuminate the role of clearance mechanisms in heart failure progression .

In renal disorders, dual immunofluorescence studies using NPR-C antibodies alongside markers for specific nephron segments can identify the precise renal structures where NPR-C function may be compromised. This approach helps elucidate the molecular basis of altered sodium handling and fluid balance in pathological states .

Additionally, co-immunoprecipitation experiments using NPR-C antibodies can identify novel protein-protein interactions that may be dysregulated in disease states, potentially revealing new therapeutic targets for cardiovascular and renal disorders .

What methodological considerations should researchers address when using NPR-C antibodies for functional studies?

When designing functional studies with NPR-C antibodies, researchers should address several critical methodological factors:

First, consider antibody format selection based on the specific application. For intracellular signaling studies, non-conjugated antibodies may be preferred for maximum flexibility, while pre-conjugated versions (such as HRP or fluorophore-conjugated) may offer advantages for direct detection in certain experimental setups .

Second, fixation protocols significantly impact epitope accessibility and detection sensitivity, particularly for membrane proteins like NPR-C. The protocol used with ab14355 (4% formaldehyde fixation for 10 minutes) has proven effective for ICC/IF applications . Researchers should optimize fixation conditions based on their specific cell type and application.

Third, when studying NPR-C's role in clearing natriuretic peptides, researchers should consider competitive binding assays using labeled natriuretic peptides alongside NPR-C antibodies to determine if the antibody interferes with ligand binding. This is crucial when using antibodies to modulate receptor function rather than simply detect it.

Fourth, for transfection studies examining NPR-C variants or mutants, researchers should verify that the epitope recognized by the antibody remains intact in the modified protein. The epitope for ab14355 lies within amino acids 150-250 of human NPR3 , so mutations in this region may affect antibody recognition.

Finally, implement tissue-specific optimization, as receptor expression and accessibility may vary between tissue types. Antigen retrieval methods should be empirically determined for each tissue when performing immunohistochemistry.

How do recent findings on neuropeptide receptors inform research approaches with NPR-C?

Recent research on neuropeptide receptors, particularly studies on NPR-15 in C. elegans, provides valuable insights that can inform NPR-C research methodologies in mammalian systems . Although NPR-15 and NPR-C are distinct receptors, parallel research approaches may be beneficial.

One significant finding is that neuropeptide receptors can modulate transcription factor activity, as demonstrated by NPR-15's regulation of GATA/ELT-2 and TFEB/HLH-30 transcription factors . Researchers working with NPR-C should consider investigating similar transcriptional regulatory networks by combining NPR-C antibody-based chromatin immunoprecipitation with transcriptomic analyses to identify downstream transcriptional targets.

Additionally, the discovery that neural G-protein-coupled receptors regulate both immunity and behavioral responses suggests that NPR-C may have unexplored roles beyond cardiovascular and renal systems. Researchers could employ NPR-C antibodies in neuronal and immune cell studies to explore potential cross-system regulatory functions.

The finding that amphid sensory neurons are involved in neuropeptide receptor signaling indicates that researchers should investigate NPR-C expression and function in sensory neurons using sensitive detection methods like immunofluorescence with confocal microscopy.

Furthermore, the observation that neuropeptide receptor mutations affect bacterial colonization and pathogen resistance suggests that NPR-C might play roles in mucosal immunity and barrier function. Researchers could use NPR-C antibodies to study its expression in epithelial barriers and investigate its potential immunomodulatory functions.

What are the key considerations for developing comprehensive experimental protocols using NPR-C antibodies?

Developing robust experimental protocols with NPR-C antibodies requires attention to several critical factors to ensure reproducible and meaningful results:

First, implement proper antibody titration to determine optimal concentrations for each application. For the NPR-C antibody (E-5) from Santa Cruz Biotechnology, which is supplied at 200 μg/ml , researchers should perform serial dilutions to identify the minimum concentration that provides specific signal with minimal background.

Second, design appropriate controls, including:

• Positive controls: tissues or cells known to express NPR-C

• Negative controls: tissues or cells with minimal NPR-C expression

• Technical controls: secondary antibody-only staining to assess non-specific binding

• Biological validation: using siRNA knockdown or CRISPR knockout models to confirm specificity

Third, consider complementary approaches to enhance interpretation of antibody-based results. For example, couple antibody detection with mRNA expression analysis using RT-qPCR or RNA-seq to correlate protein and transcript levels of NPR-C.

Fourth, when studying NPR-C's regulation of natriuretic peptide levels, design experiments that measure both receptor expression (using antibodies) and functional outcomes (measuring peptide clearance rates). This multi-parameter approach provides a more comprehensive understanding of the receptor's biological role.

Finally, for reproducibility across different studies, thoroughly document all experimental conditions, including antibody lot numbers, incubation times, buffer compositions, and image acquisition parameters. This level of detail is essential for protocol standardization in the research community.

How might emerging technologies enhance the utility of NPR-C antibodies in research?

The integration of NPR-C antibodies with emerging technologies presents exciting opportunities for advancing research in this field:

Single-cell antibody-based techniques, such as mass cytometry (CyTOF) or imaging mass cytometry, could revolutionize our understanding of NPR-C expression heterogeneity across cell populations. By conjugating NPR-C antibodies with metal isotopes, researchers could simultaneously evaluate receptor expression alongside dozens of other cellular markers at single-cell resolution .

Super-resolution microscopy techniques (STORM, PALM, STED) combined with fluorophore-conjugated NPR-C antibodies could reveal nanoscale receptor organization and clustering on cell membranes. This approach would provide unprecedented insights into how receptor spatial organization influences natriuretic peptide binding and clearance dynamics.

Proximity labeling methods (BioID, APEX) coupled with NPR-C antibodies for validation could map the complete interactome of NPR-C in different physiological and pathological contexts. This would identify novel interaction partners that might regulate receptor function or mediate downstream signaling.

Microfluidic organ-on-chip models coupled with immunofluorescence using NPR-C antibodies could facilitate dynamic studies of receptor regulation under controlled fluid flow conditions that mimic physiological environments, particularly relevant for cardiovascular and renal research.

CRISPR-engineered reporter cell lines with epitope-tagged NPR-C could be validated using existing NPR-C antibodies and then employed for high-throughput screening of compounds that modulate receptor expression, localization, or function.

What insights from NPR-C research might be applicable to studying other neuropeptide receptors?

Research methodologies and findings from NPR-C studies provide valuable frameworks that could be adapted for investigating other neuropeptide receptors:

The dual role of NPR-C in signaling and clearance suggests that other neuropeptide receptors might similarly serve multiple functions beyond canonical signaling. Researchers should design experiments that can distinguish between signaling and clearance functions, potentially using antibodies that specifically block one function without affecting the other.

The discovery that neuropeptide receptors like NPR-15 in C. elegans modulate transcription factor activity indicates that NPR-C and other neuropeptide receptors might have underappreciated roles in transcriptional regulation. Researchers could employ chromatin immunoprecipitation sequencing (ChIP-seq) to identify genomic regions affected by receptor activation or inhibition.

The finding that amphid sensory neurons are involved in neuropeptide receptor signaling in C. elegans suggests that sensory neuron expression of various neuropeptide receptors, including potential mammalian homologs of NPR-15, should be systematically investigated. This could reveal novel sensory roles for these receptors in detecting environmental or physiological changes.

The observation that NPR-15 controls avoidance behavior through TRPM ion channels raises the possibility that NPR-C and other neuropeptide receptors might similarly modulate ion channel function in mammals. Electrophysiological studies combined with antibody-based receptor localization could explore these potential functional interactions.

The enhanced bacterial pathogen resistance observed in NPR-15 mutant C. elegans suggests that neuropeptide receptors may broadly influence immune function. This presents an opportunity to explore potential immunomodulatory roles of NPR-C and related receptors using antibody-based detection methods in immune cell populations.